5,5-dimethyl-1-pyrroline-1-oxide has been researched along with Dementia in 1 studies
5,5-dimethyl-1-pyrroline-1-oxide: do not confuse with DMPO (4',5'-dihydroxy-7-methoxy-4-phenyl-5,2'-oxidocoumarin)
5,5-dimethyl-1-pyrroline N-oxide : A member of the class of 1-pyrroline nitrones (1-pyrroline N-oxides) resulting from the formal N-oxidation of 5,5-dimethyl-1-pyrroline. Used as a spin trap for the study of radicals formed by enzymatic acetaldehyde oxidation.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kasparová, S | 1 |
Brezová, V | 1 |
Valko, M | 1 |
Horecký, J | 1 |
Mlynárik, V | 1 |
Liptaj, T | 1 |
Vancová, O | 1 |
Ulicná, O | 1 |
Dobrota, D | 1 |
1 other study available for 5,5-dimethyl-1-pyrroline-1-oxide and Dementia
Article | Year |
---|---|
Study of the oxidative stress in a rat model of chronic brain hypoperfusion.
Topics: Animals; Ascorbic Acid; Brain; Brain Ischemia; Chronic Disease; Creatine Kinase; Cyclic N-Oxides; De | 2005 |